Skip to main content

Relpax News

Combination Therapy Recommended For Migraines

THURSDAY, March 20, 2025 – Doctors should prescribe triptans for migraine patients who aren’t receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from t...

FDA Medwatch Alert: Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of Relpax (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products

Pfizer Inc. is voluntarily recalling Relpax (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer Inc. initiated this recall because these product lots may not...

FDA Medwatch Alert: 5-Hydroxytryptamine Receptor Agonists (Triptans) - Serotonin Syndrome

[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine

Relpax patient information at Drugs.com